PIONEER是欧洲卓越大数据前列的网络，共有来自欧洲9个国家的37个公共和私营利益相关者。前列腺癌的管理已经取得了很多进展，但该领域仍存在许多未解决的问题，大数据可以帮助解决这些问题。PIONEER联盟进行了两轮修订后的Delphi调查，旨在建立健康专业人员和前列腺癌患者之间各自提出的重要问题，以便利用大数据回答这些问题。受访者被要求考虑，回答这些问题将对改善前列腺癌患者的诊断和治疗效果产生何种影响，并在1（不重要）到9（非常重要）的评分中给出分数。在两个相关方团体中，评分为“非常重要”的预定问题的参与者平均百分比被计算，用于对问题进行排名并确定关键重要类别中的最高得分问题。确定对于各方利益相关者而言重要的前列腺癌问题，将有助于PIONEER联盟回答这些问题，以改善前列腺癌患者的临床护理。©2023. Springer Nature Limited.

PIONEER is a European network of excellence for big data in prostate cancer consisting of 37 private and public stakeholders from 9 countries across Europe. Many progresses have been done in prostate cancer management, but unanswered questions in the field still exist, and big data could help to answer these questions. The PIONEER consortium conducted a two-round modified Delphi survey aiming at building consensus between two stakeholder groups - health-care professionals and patients with prostate cancer - about the most important questions in the field of prostate cancer to be answered using big data. Respondents were asked to consider what would be the effect of answering the proposed questions on improving diagnosis and treatment outcomes for patients with prostate cancer and to score these questions on a scale of 1 (not important) to 9 (critically important). The mean percentage of participants who scored each of the proposed questions as critically important was calculated across the two stakeholder groups and used to rank the questions and identify the highest scoring questions in the critically important category. The identification of questions in prostate cancer that are important to various stakeholders will help the PIONEER consortium to provide answers to these questions to improve the clinical care of patients with prostate cancer.© 2023. Springer Nature Limited.